|
|
|
|
|
Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women. |
2560 |
# |
|
|
|
|
|
Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women. |
2559 |
# |
|
|
|
|
|
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine |
2564 |
# |
|
|
|
|
|
Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution |
2565 |
# |
|
|
|
|
|
Immunogenicity of a live-attenuated human rotavirus RIX4414 vaccine with or without buffering agent |
2553 |
# |
|
|
|
|
|
Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination with Live Attenuated SA14-14-2 Vaccine: A Phase IV Study in Thai Children. |
2560 |
# |
|
|
|
|
|
Immunogenicity of a human rotavirus vaccine (RIX4414) after storage at 37 degrees C for seven days |
2554 |
# |
|
|
|
|
|
Immunogenicity and tolerability of an AS03A-adjuvanted prepandemic influenza vaccine: A phase III study in a large population of Asian adults |
2552 |
# |
|
|
|
|
|
Immunogenicity and safety study of a new DTaP-IPV-Hep B-PRP-T combined vaccine compared to a licensed DTaP-IPV-Hep B//PRP-T comparator, both concomitantly administered with a 7-valent pneumococcal conjugate vaccine at 2, 4 and 6 months of age in Thai |
2554 |
# |
|
|
|
|
|
Immunogenicity and safety profiles of a new MAV/06 strain varicella vaccine in healthy children: A multinational, multicenter, randomized, double-blinded, active-controlled phase III study |
2564 |
# |
|
|
|
|
|
Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children |
2554 |
# |
|
|
|
|
|
Immunogenicity and safety of measles-mumps-rubella vaccine at two different potency levels administered to healthy children aged 12-15 months: A phase III, randomized, non-inferiority trial The MMR-161 Study Group |
2561 |
# |
|
|
|
|
|
Immunogenicity and Safety of an MF59-adjuvanted Quadrivalent Seasonal Influenza Vaccine in Young Children at High Risk of Influenza-associated Complications: A Phase III, Randomized, Observer-blind, Multicenter Clinical Trial |
2563 |
# |
|
|
|
|
|
IMMUNOGENICITY AND SAFETY OF AN INACTIVATED PANDEMIC H1N1 VACCINE PROVIDED BY THE THAI MINISTRY OF PUBLIC HEALTH AS A ROUTINE PUBLIC HEALTH SERVICE |
2555 |
# |
|
|
|
|
|
Immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine as a booster dose in 12- to 18-month-old children primed with 3 doses of 7-valent pneumococcal conjugate vaccine. |
2557 |
# |
|
|
|
|
|
Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant: A Systematic Review and Meta-Analysis |
2565 |
# |
|
|
|
|
|
Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases |
2565 |
# |
|
|
|
|
|
Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults |
2565 |
# |
|
|
|
|
|
Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines |
2563 |
# |
|
|
|
|
|
Immunogenic response in obese patients undergoing rabies post-exposure prophylaxis with combined equine rabies immunoglobulin and rabies vaccination. |
2561 |
# |
|
|
|
|
|
Immunogenic response in obese patients undergoing rabies post-exposure prophylaxis with combined equine rabies immunoglobulin and rabies vaccination. |
2560 |
# |
|
|
|
|
|
Immunodominant T-cell responses to dengue virus NS3 are associated with DHF |
2553 |
# |
|
|
|
|
|
Immunodominant linear B cell epitopes in the spike and membrane proteins of SARS-CoV-2 identified by immunoinformatics prediction and immunoassay |
2564 |
# |
|
|
|
|
|
Immunodiagnosis for cervical cancer using antibody-gold nanoparticle conjugate |
2555 |
# |
|
|
|
|
|
Immunodeficiency in Children Starting Antiretroviral Therapy in Low-, Middle-, and High-Income Countries |
2557 |
# |
|
|
|
|
|
Immunocompromised patients with acute respiratory distress syndrome: Secondary analysis of the LUNG SAFE database |
2561 |
# |
|
|
|
|
|
Immunocompromised group differences in the presentation of intestinal strongyloidiasis. |
2551 |
# |
|
|
|
|
|
Immunochromatographic test for rapid serological diagnosis of human angiostrongyliasis. |
2561 |
# |
|
|
|
|
|
Immunobiological properties of influenza A (H7N9) hemagglutinin and neuraminidase proteins. |
2559 |
# |
|
|
|
|
|
Immunoarchitectural patterns of progressive transformation of germinal centers with and without nodular lymphocyte-predominant Hodgkin lymphoma |
2558 |
# |